Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

MRVIMRVI
23 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in MARAVAI LIFESCIENCES HLDGS I

CITADEL ADVISORS LLC holds 2.1M shares of MRVI (MARAVAI LIFESCIENCES HLDGS I), worth $13.2M as of 2026-Q2. The position was increased (+43.0% shares). MRVI represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$13.2M

Current Shares

2.1M

Total Value Change

-$19.7M

Total Shares Change

+949,069

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.1M
+43.0%
$13.2M0.0%$6.24
38
2026-Q1
Increased
1.5M
+140.4%
$4.2M0.0%$3.69
43
2025-Q4
Increased
617,454
+594.9%
$2M0.0%$3.27
42
2025-Q3
Decreased
88,854
-85.4%
$255,0110.0%$2.83
0
2025-Q2
Decreased
608,738
-43.0%
$1.5M0.0%$2.47
0
2025-Q1
Increased
1.1M
+4997.0%
$2.4M0.0%$2.36
42
2024-Q4
New
20,969
-
$114,2810.0%$5.51
34
2024-Q3
Exited
0
-100.0%
$00.0%$8.42
0
2024-Q2
Increased
357,549
+32.4%
$2.6M0.0%$7.16
33
2024-Q1
Decreased
270,163
-76.4%
$2.3M0.0%$8.67
0
2023-Q4
Decreased
1.1M
-35.0%
$7.5M0.0%$6.55
0
2023-Q3
Increased
1.8M
+107x
$17.6M0.0%$10.00
46
2023-Q2
Decreased
16,356
-96.9%
$203,3050.0%$12.51
0
2023-Q1
Increased
520,557
+4.9%
$7.3M0.0%$13.50
29
2022-Q4
Decreased
496,282
-72.8%
$7.1M0.0%$14.31
0
2022-Q3
Increased
1.8M
+1239.2%
$46.6M0.0%$25.42
47
2022-Q2
Decreased
136,209
-68.7%
$3.9M0.0%$27.81
0
2022-Q1
Increased
434,891
+75.8%
$15.3M0.0%$35.63
43
2021-Q4
Decreased
247,303
-81.2%
$10.4M0.0%$41.86
0
2021-Q3
Increased
1.3M
+99.1%
$64.7M0.0%$48.42
48
2021-Q2
Increased
661,713
+106.4%
$27.6M0.0%$42.79
46
2021-Q1
Decreased
320,538
-72.7%
$11.4M0.0%$33.99
0
2020-Q4
New
1.2M
-
$32.9M0.0%$27.97
40

Other major holders of MRVI: Select Equity Group, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used